Showing results (171-180 of 192) with videos related to

Sort By:
Pageof 20
Critical Care (London, England)|October 31, 2024
Effect of therapeutic plasma exchange on tissue factor and tissue factor pathway inhibitor in septic shockKlaus Stahl, Georg F Lehner, Pedro David Wendel-Garcia, et al.
ESMO Open|August 30, 2024
PF-06952229, a selective TGF-β-R1 inhibitor: preclinical development and a first-in-human, phase I, dose-escalation study in advanced solid tumorsT A Yap, A D Choudhury, E Hamilton, et al.
Blood|May 1, 1996
A randomized placebo-controlled trial of recombinant human interleukin-11 in cancer patients with severe thrombocytopenia due to chemotherapyI Tepler, L Elias, J W Smith, et al.
Intensive Care Medicine Experimental|November 24, 2021
Effects of therapeutic plasma exchange on the endothelial glycocalyx in septic shockKlaus Stahl, Uta Carola Hillebrand, Yulia Kiyan, et al.
Transplantation|February 26, 2019
Greater Susceptibility for Metabolic Syndrome in Pediatric Solid Organ and Stem Cell Transplant RecipientsRicarda Blöte, Nima Memaran, Bianca Borchert-Mörlins, et al.
Pediatric Cardiology|April 8, 2022
Impact of Sex and Obesity on Echocardiographic Parameters in Children and AdolescentsJeannine von der Born, Sarah Baberowski, Nima Memaran, et al.
Transplantation|January 4, 2022
Cardiovascular Burden Is High in Pediatric Lung Transplant RecipientsNima Memaran, Mareike Onnen, Carsten Müller, et al.
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|February 12, 2019
High Burden of Subclinical Cardiovascular Target Organ Damage After Pediatric Liver TransplantationNima Memaran, Bianca Borchert-Mörlins, Bernhard M W Schmidt, et al.
Critical Care (London, England)|May 13, 2022
Clinical and biochemical endpoints and predictors of response to plasma exchange in septic shock: results from a randomized controlled trialKlaus Stahl, Philipp Wand, Benjamin Seeliger, et al.
Blood|May 1, 1997
Recombinant methionyl human stem cell factor and filgrastim for peripheral blood progenitor cell mobilization and transplantation in non-Hodgkin's lymphoma patients--results of a phase I/II trialC H Moskowitz, P Stiff, M S Gordon, et al.
Pageof 20